Total Payments
$5,751
2024 Payments
$269.05
Companies
31
Transactions
223
Medicare Patients
4,384
Medicare Billing
$450,944
Payment Breakdown by Category
Food & Beverage$3,546 (61.7%)
Other$2,205 (38.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,546 | 217 | 61.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,205 | 2 | 38.3% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
General
$5,751
219 transactions
Ownership
$0
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| FUJIFILM Medical Systems USA, Inc. | $2,205 | 2 | $0 (2017) |
| ABBVIE INC. | $778.48 | 52 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $524.85 | 39 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $385.25 | 21 | $0 (2024) |
| Janssen Biotech, Inc. | $303.13 | 14 | $0 (2024) |
| QOL Medical, LLC | $176.01 | 11 | $0 (2022) |
| RedHill Biopharma Inc. | $164.83 | 9 | $0 (2023) |
| Braintree Laboratories, Inc. | $125.15 | 8 | $0 (2022) |
| Merck Sharp & Dohme LLC | $121.57 | 8 | $0 (2022) |
| Gilead Sciences, Inc. | $107.56 | 6 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $269.05 | 16 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($95.11) |
| 2023 | $635.23 | 37 | Takeda Pharmaceuticals U.S.A., Inc. ($191.90) |
| 2022 | $303.12 | 20 | ABBVIE INC. ($120.81) |
| 2021 | $451.57 | 32 | AbbVie Inc. ($166.87) |
| 2020 | $424.03 | 28 | AbbVie Inc. ($129.47) |
| 2019 | $517.26 | 32 | Janssen Biotech, Inc. ($115.67) |
| 2018 | $549.93 | 33 | AbbVie, Inc. ($168.91) |
| 2017 | $2,601 | 25 | FUJIFILM Medical Systems USA, Inc. ($2,205) |
All Payment Transactions
223 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/30/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: IMMUNOLOGY | ||||||
| 07/26/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/12/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: Gastroenterology | ||||||
| 06/21/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ, HUMIRA | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: IMMUNOLOGY | ||||||
| 06/13/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/04/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Immunology | ||||||
| 04/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Gastroenterology | ||||||
| 03/01/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Immunology | ||||||
| 02/27/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Gastroenterology | ||||||
| 01/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Gastroenterology | ||||||
| 01/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Gastroenterology | ||||||
| 01/10/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Immunology | ||||||
| 2024 | GastroGPO, LLC | — | — | — | $0.00 | Ownership |
| 12/15/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/14/2023 | CapsoVision, Inc. | CapsoCam Plus (Device) | Food and Beverage | Cash or cash equivalent | $14.17 | General |
| Category: Gastroenterology | ||||||
| 12/12/2023 | Evoke Pharma, Inc. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Gastroenterology | ||||||
| 12/11/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Gastroenterology | ||||||
| 12/05/2023 | RedHill Biopharma Inc. | Talicia (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: Antibiotic | ||||||
| 11/20/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/14/2023 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 11/08/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: Gastroenterology | ||||||
| 11/01/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,015 | 1,240 | $541,381 | $100,554 |
| 2022 | 13 | 1,151 | 1,541 | $616,071 | $119,870 |
| 2021 | 15 | 1,186 | 1,550 | $609,523 | $123,065 |
| 2020 | 13 | 1,032 | 1,408 | $504,260 | $107,455 |
Total Patients
4,384
Total Services
5,739
Medicare Billing
$450,944
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 103 | 257 | $51,400 | $16,922 | 32.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 98 | 100 | $124,476 | $15,380 | 12.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 117 | 128 | $38,400 | $13,237 | 34.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 124 | 129 | $119,250 | $9,846 | 8.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 42 | 43 | $61,275 | $9,366 | 15.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 75 | 87 | $18,444 | $8,481 | 46.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 76 | 93 | $13,950 | $6,542 | 46.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 74 | 74 | $18,500 | $6,289 | 34.0% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 17 | 17 | $24,378 | $3,344 | 13.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 16 | 16 | $22,944 | $3,137 | 13.7% |
| 43246 | Insertion of stomach tube using a flexible endoscope | Facility | 2023 | 17 | 17 | $19,550 | $2,805 | 14.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $5,904 | $2,232 | 37.8% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 13 | 13 | $15,470 | $1,804 | 11.7% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 225 | 248 | $7,440 | $1,170 | 15.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 160 | 459 | $91,800 | $26,477 | 28.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 170 | 190 | $57,000 | $20,733 | 36.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 121 | 122 | $151,158 | $18,849 | 12.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 124 | 126 | $113,400 | $10,104 | 8.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 43 | 46 | $65,550 | $9,992 | 15.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 79 | 97 | $20,564 | $9,424 | 45.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 81 | 81 | $20,250 | $6,224 | 30.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 61 | 73 | $10,950 | $5,018 | 45.8% |
| 43246 | Insertion of stomach tube using a flexible endoscope | Facility | 2022 | 24 | 25 | $28,750 | $4,277 | 14.9% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 25 | 26 | $29,695 | $3,750 | 12.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 23 | 23 | $7,544 | $2,853 | 37.8% |
About Dr. Harsh Gupta, MD
Dr. Harsh Gupta, MD is a Gastroenterology healthcare provider based in Evanston, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1295727436.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Harsh Gupta, MD has received a total of $5,751 in payments from pharmaceutical and medical device companies, with $269.05 received in 2024. These payments were reported across 223 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($3,546).
As a Medicare-enrolled provider, Gupta has provided services to 4,384 Medicare beneficiaries, totaling 5,739 services with total Medicare billing of $450,944. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Evanston, IL
- Active Since 08/15/2005
- Last Updated 12/28/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1295727436
Products in Payments
- ESD - Core Endoscopy (Device) $844.50
- ENTYVIO (Biological) $322.50
- XIFAXAN (Drug) $313.57
- STELARA (Biological) $217.34
- Mavyret (Drug) $183.78
- Entyvio (Biological) $171.92
- HUMIRA (Biological) $171.49
- Talicia (Drug) $164.83
- LINZESS (Drug) $105.39
- MAVYRET (Drug) $100.52
- SUCRAID (Drug) $96.58
- DIFICID (Drug) $85.90
- REMICADE (Biological) $85.79
- RINVOQ (Biological) $81.19
- GIMOTI (Drug) $80.41
- Sucraid (Drug) $79.43
- SUPREP (Drug) $78.87
- Humira (Biological) $74.95
- CREON (Drug) $74.65
- IBSRELA (Drug) $55.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Evanston
Dr. Daksesh Patel, D.o, D.O
Gastroenterology — Payments: $554,798
Gastroenterology $554,798
Eugene Yen, Md, MD
Gastroenterology — Payments: $218,003
Gastroenterology $218,003
Dr. John Vainder, Md, MD
Gastroenterology — Payments: $9,597
Gastroenterology $9,597
Farhan Quader, Md, MD
Gastroenterology — Payments: $3,991
Gastroenterology $3,991
Anuhya Gampa, M.d, M.D
Gastroenterology — Payments: $1,393
Gastroenterology $1,393
Laura Bianchi, Md, MD
Gastroenterology — Payments: $1,120
Gastroenterology $1,120